Acute Olfactory Hypersensitivity to Opium and Cannabis Following Naltrexone Administration: A Rare Case Report
Open Access
- 9 May 2026
- journal article
- Published by Maad Rayan Publishing Company in Addiction & Health
- Vol. 18 (1) , 1-4
Abstract
Naltrexone, a long-acting opioid receptor antagonist, is commonly utilized to avert relapse in individuals with opioid or alcohol dependence. While its efficacy in modifying cue-reactivity and lowering desire is well documented, less is known regarding its ability to elicit negative sensory-emotional reactions, particularly in response to olfactory stimulation. We present a rare case of a 16-year-old male with a history of cannabis usage who experienced acute episodes of respiratory distress after starting oral naltrexone (50 mg/day). These episodes were consistently triggered by the smell of opium or cannabis smoke, despite the patient’s abstinence. The reactions were severe enough to necessitate multiple emergency medical procedures. The patient had a prior adverse reaction to morphine and a history of multiple drug allergies, suggesting a possible underlying sensitivity to opioid system modulation. The symptoms resolved after discontinuation of naltrexone. This case raises significant clinical and neurobiological concerns about the role of opioid antagonism in modifying olfactory and emotional processing. We propose that naltrexoneinduced disinhibition in olfactory-limbic circuits may have contributed to heightened sensory gain and conditioned unpleasant reactions in a sensitized individual. More research is needed to understand the mechanisms driving this unusual yet important reaction.Keywords
This publication has 19 references indexed in Scilit:
- Naltrexone attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in miceBehavioural Brain Research, 2021
- Taste and Smell Alterations and Substance Use Disorders2021
- Insights into the Neurobiology of Craving in Opioid Use DisorderCurrent Anesthesiology Reports, 2020
- Sweet taste pleasantness is modulated by morphine and naltrexonePsychopharmacology, 2016
- The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in HumansNeuropsychopharmacology, 2016
- Neuroimaging the Effectiveness of Substance Use Disorder TreatmentsJournal of Neuroimmune Pharmacology, 2016
- Naltrexone: Not Just for Opioids AnymoreJournal of Medical Toxicology, 2015
- Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: A bold FMRI studyNeuroImage, 2013
- Targeted Opioid Receptor Antagonists in the Treatment of Alcohol Use DisordersCNS Drugs, 2013
- Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment.Experimental and Clinical Psychopharmacology, 2007